Scopus by Title (Ref)

Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy

Journal of Medical Virology

April 2019

Khan A.J.

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

Plos One

July 2018

Wei L.

Open Access

Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism

Gastroenterology Report

1 August 2017

Ekstrom V.

Open Access

A new prognostic test of the effectiveness of antiviral therapy for CHC and its comparative assessment with detection of IL28B gene polymorphism

Infektsionnye Bolezni

2017

Khokhlova O.N.

Hepatitis B virus infection in Chinese patients with hepatitis C virus infection: Prevalence, clinical characteristics, viral interactions and host genotypes: A nationwide cross-sectional study

BMJ Open

1 October 2016

Yan L.B.

Open Access

Interferon Lambda 4 polymorphism predicts sustained viral response in hepatitis C virus patients irrespective of hepatitis C virus genotypes, ethnicity or treatment regimen: Results from a meta-analysis

Hepatitis Monthly

19 December 2015

Wu Q.

Open Access

A comprehensive long-term prognosis of chronic hepatitis C patients with antiviral therapy: A meta-analysis of studies from 2008 to 2014

Hepatitis Monthly

23 May 2015

Wen Y.

Open Access

Role of interferon gamma and tumor necrosis factor-related apoptosis-inducing ligand receptor 1 single nucleotide polymorphism in natural clearance and treatment response of HCV infection

Viral Immunology

1 May 2015

Azam S.

The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection

Archives of Virology

April 2015

Wang M.